Lexagene Holdings Inc LXXGQ

Healthcare Medical Devices

Lexagene Holdings Inc. is a molecular diagnostics company engaged in researching, developing and commercializing automated genetic analyzer devices in clinical and life science industries. The Company is focused on developing molecular diagnostic systems for pathogen detection and genetic testing for other molecular markers for on-site rapid testing in veterinary diagnostics, and for use in open-access markets such as food and water safety, clinical research, agricultural testing and biodefense. The Company's MiQLab System is an automated, open-access molecular diagnostic system for pathogen detection, allowing users to test for multiple pathogens onsite, returning results in approximately 2 hours. Its MiQLab System is an automated, multiplexing polymerase chain reaction (PCR)-based system designed for syndromic testing in human clinical diagnostics and veterinary diagnostics, as well as food safety testing, and open-access custom testing markets.

GREY:LXXGQ - Post by User

Lexagene Holdings Inc > You were right ragb

<< Previous

Bullboard Posts

Next >>

Comment by letsdoiton Aug 05, 2020 9:56am

76 Views

Post# 31366183

RE:RE:RE: You were right ragb

yahoo board ragb, they're in a volume driven market and it's going to cost $19,000 per unit to manufacture, plain ridiculous, millions of people around the world wanting a Covid test, thousands and thousands of vets and it's costing nearly $2 million for a paltry 100 units, madness

<< Previous

Bullboard Posts

Next >>

Advancing flagship Ishkõday Gold Project in Ontario